Tag: inspection

Identifying and Addressing the Impact of Skipped IPCs During Scale-Up in Pharma Manufacturing In pharmaceutical manufacturing, adherence to in-process controls (IPCs) is paramount to ensure product integrity and compliance with…

Assessing the Impact of Unplanned Hold Time Extensions During Changeovers: A Case Study In the highly regulated environment of pharmaceutical manufacturing, unplanned hold time extensions during changeover processes can lead…

Analyzing an Unapproved Change in Process Parameters During a Commercial Campaign During a recent commercial-scale pharmaceutical manufacturing campaign, a significant deviation was detected involving an unapproved change in process parameters.…

Assessment of Unapproved Changes During Pharmaceutical Tech Transfer: A Case Study In the complex world of pharmaceutical manufacturing, deviations from established processes can lead to significant regulatory impacts and risks…

Analyzing Deviations across Batches During Technology Transfer: A Case Study on FDA Observations Technology transfer in pharmaceutical manufacturing is a critical process that can introduce risks, including the potential for…

Case Study: Assessing the Regulatory Impact of Unplanned Hold Time Extensions During Inspection Preparation In pharmaceutical manufacturing, the unexpected occurrence of unplanned hold time during inspection preparation can significantly compromise…

Breaking Down FDA Observations: Equipment Used Without Release in Manufacturing In pharmaceutical manufacturing, ensuring compliance with Good Manufacturing Practice (GMP) is critical to maintaining product quality and regulatory approval. This…

Case Study: Impact of Unapproved Process Change during Routine Manufacturing In a recent incident at a pharmaceutical manufacturing facility, a process change was implemented without the necessary Quality Assurance (QA)…

Assessment of a Manufacturing Process Change Implemented Without QA Approval In the highly regulated pharmaceutical industry, adherence to established protocols is paramount. This case study discusses a significant deviation where…

Case Study: Addressing a Deviation Closed Without Effectiveness Check During Changeover Understanding and resolving manufacturing deviations is critical in pharmaceutical production. This case study focuses on a specific instance where…

“`html Root Cause Analysis in Pharmaceutical Manufacturing: Addressing the Execution of a Batch with Expired SOP In a recent real-world scenario, a pharmaceutical manufacturer discovered that a batch of product…

Breakdown of FDA Inspection Observations Following an Unapproved Process Parameter Change During Commercial Campaign In the highly regulated environment of pharmaceutical manufacturing, adhering to established process parameters is critical. A…